Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease
NCT06446219
·
clinicaltrials.gov ↗
COMPLETED
Status
172
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University